ALEXIS LEE: Open Payments
NPI 1770010456 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,574 in 91 payments from 25 companies in 2025. Trend: 2023 $2,176 · 2024 $5,645 · 2025 $7,574
Speaker / faculty: $2,750Food & beverage: $2,249Consulting: $1,350Travel & lodging: $1,132Education: $93
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $3,236 |
| Daiichi Sankyo Inc. | 9 | $2,733 |
| Regeneron Healthcare Solutions, Inc. | 11 | $379 |
| Janssen Biotech, Inc. | 11 | $253 |
| Novartis Pharmaceuticals Corporation | 7 | $146 |
| Caris MPI, Inc. | 6 | $105 |
| Exelixis Inc. | 4 | $94 |
| SpringWorks Therapeutics, Inc. | 3 | $73 |
| BeOne Medicines USA, Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
Products named: DATROWAY, LIBTAYO, RYBREVANT, KISQALI, MI CANCER SEEK, CABOMETYX, GOMEKLI, TEVIMBRA.
Industry payments across TN — which companies pay providers there.
